Five-Year Outcomes of Zotarolimus- and Everolimus-Eluting Stents
This secondary analysis of a randomized clinical trial evaluates the 5-year outcomes of zotarolimus-eluting stents vs everolimus-eluting stents to treat randomized participants and nonenrolled eligible patients with non–ST-segment elevation acute coronary syndromes.